Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Cookie preferences
Back to Industry News
Medtech

Singapore Medtech Startup Magloy Tech Founded by Manakari, Parande

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Forbes
TL;DR

TL;DR: Manakari and Parande, guided by their Ph.D. supervisor at the National University of Singapore, established Magloy Tech, a medtech startup in Singapore. Their primary product, OrthoMag, is a bone implant made of biocompatible magnesium alloy designed to dissolve naturally as the bone heals.

Key takeaways

  • Manakari and Parande, along with their Ph
  • supervisor from the National University of Singapore, co-founded Magloy Tech, a Singapore-based medtech startup
  • The company's flagship product, OrthoMag, is a novel bone implant crafted from a biocompatible magnesium alloy
Manakari and Parande, along with their Ph.D. supervisor from the National University of Singapore, co-founded Magloy Tech, a Singapore-based medtech startup. The company's flagship product, OrthoMag, is a novel bone implant crafted from a biocompatible magnesium alloy. OrthoMag is designed to dissolve naturally within the body as the bone heals. This innovative approach potentially minimizes patient risk and accelerates recovery by eliminating the need for a secondary surgical procedure typically required for removing conventional steel or titanium implants.

Related Topics

medtechstartupSingaporeMagloy TechManakariParande

Verified mention available

Free to claim

Is this your company?

Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.

Set up alerts Takes under 1 minute • Verified manually

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original